Treatment of Acute Pericarditis With Anakinra

Stopped early · Phase 2 · Has a placebo group

Conditions studied: Acute Pericarditis

In brief

The goal of this study is to determine the safety and efficacy of anakinra for the treatment of acute pericarditis when initiated within 6 hours of diagnosis and continued for 3 or 7 days. 1. to determine the efficacy of anakinra with respect to chest pain resolution 2. to determine the safety of anakinra with respect to adverse drug events

Key facts

Study ID
NCT03224585
Run by
Virginia Commonwealth University
People needed
5
Starts
2018-05-11
Expected to finish
2020-02-01
Last updated by the study team
2021-02-23

Who can join

Age: 12 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.